Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Stephanie S Yee

10PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisGene expression (incl. microarray and other genome-wide approaches)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Mar 22, 2022
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung

|Jun 07, 2021
Serial Monitoring of Circulating Tumor DNA by Next-Generation Gene Sequencing as a Biomarker of Response and Survival in Patients With Advanced NSCLC Receiving Pembrolizumab-Based Therapy.

Jeffrey C Thompson, Erica L Carpenter, Benjamin A Silva

|Oct 17, 2020
THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement.

Shirsa Udgata, Naomi Takenaka, William R Bamlet

|Oct 03, 2020
Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide.

Naomi B Haas, Michael J LaRiviere, Thomas H Buckingham

|Apr 18, 2020
A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma.

Zijian Yang, Michael J LaRiviere, Jina Ko

|Feb 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

Charu Aggarwal, Jeffrey C Thompson, Austin L Chien

Pageof 2

Frequent Collaborators

2 joint publications

Jacob E Till

2 joint publications

Michael J LaRiviere

2 joint publications

Joshua M Bauml

2 joint publications

Erica L Carpenter

1 joint publications

Samantha Guiry

1 joint publications

MacLean P Nasrallah

1 joint publications

Jennifer J D Morrissette

1 joint publications

Benjamin A Silva

1 joint publications

Kimberly C Banks

1 joint publications

Jeffrey S Wasser

Frequent Collaborators

2 joint publications

Jacob E Till

2 joint publications

Michael J LaRiviere

2 joint publications

Joshua M Bauml

2 joint publications

Erica L Carpenter

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.3K
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.4K
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

1.2K
See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.3K
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on : Sep 08, 2023

1.4K
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

1.2K
See more related videos